论文信息 - A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors - 字舞流文

A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors

W. Ma | A. Adjei | G. Dy | N. Ngamphaiboon | T. Reungwetwattana | Yujie Zhao | W. Brady | G. Fetterly | Yi Ding | D. Depaolo